• Roy S, Saha S, Gupta P, Ukil A, and Das PK. (2019). Crosstalk of PD-1 signaling with SIRT1/FOXO-1 axis in progression of visceral leishmaniasis. J Cell Sci 226274.
• Saha S, Basu B, Guin S, Roy A, Gupta P, Mitterstiller AM, Weiss G. Jana K and Ukil A. (2019). Leishmania donovani exploits macrophage heme oxygenase-1 to neutralize oxidative burst and TLR signalling dependent host defense. J Immunol 202(3):827-840.
• Dowari,P., Saha S, Pramanik B, Ahmed S, Singha N,Ukil A and Das D. (2018).Multiple cross-linking strategy to form size tuneable bio-polymer with efficient cell adhesion and proliferation property. Biomacromolecules. 19(10):3994-4002.
• Gupta P., Srivastav S., Saha S., Das PK. and Ukil A. (2016). Leishmania donovani inhibits macrophage apoptosis and pro-inflammatory response through AKT-mediated regulation of β-catenin and FOXO-1. Cell Death Differ.23: 1815-1826.
• Dutta S, Lahiri S, Banerjee A, Saha S, Dasgupta D.(2015).Association of antitumor antibiotic Mithramycin with Mn2+ and the potential cellular targets of Mithramycin after association with Mn2+. J Biomol Struct Dyn 33(2):434-46.
• Saha S, Dutta A, Jana K and Ukil A.(2019). Leishmania donovani targets host transcription factor NRF2 to activate anti-oxidant enzyme HO-1 and transcriptional repressor ATF3 for establishing infection. (communicated)